Background: Cervical cancer remains one of the most prevalent cancers globally and a leading cause of cancer-related deaths among women. Early detection and precise prognostic assessment are vital for enhancing outcomes in cervical cancer patients. The purpose of this study is to evaluate the predictive value of preoperative PLR and serum albumin levels for clinicopathological outcomes in cervical cancer. Aim of the Study: The aim of the study was to evaluate the predictive value of preoperative Platelet-to-Lymphocyte Ratio and Serum Albumin levels on clinicopathological outcomes in patients with cervical cancer. Methods: This cross-sectional study, conducted at the Department of Gynecological Oncology, BSMMU, Dhaka (July 2022–June 2023), analyzed 120 women with early-stage (IA-IIA) cervical cancer to assess the association of PLR, S.Albumin for clinicopathological outcome using SPSS 27.0. Data included socio-demographics, clinical details, and serum markers. Results: The majority of participants were aged 30-44 years (46.7%) and married before 18 years of age (83.3%). Most had a PLR <128.3 (62.2%) and SA ≥3.5 (57.8%). Larger tumors (2-4 cm), higher prevalence of lymphovascular space invasion (LVSI), and deeper stromal invasion (≥½ thickness) were significantly associated with higher PLR (≥128.3) and lower SA (<3.5) (p < 0.001, p = 0.006). Conclusion: Preoperative Platelet-to-Lymphocyte Ratio and Serum Albumin levels can serve as valuable predictors of clinicopathological outcomes in cervical cancer, aiding in personalized treatment strategies.